We aimed to investigate whether combination therapy using intracoronary ( IC ) abciximab and aspiration thrombectomy ( AT ) enhances myocardial perfusion compared to each treatment alone in patients with ST-elevation myocardial infarction ( STEMI ) undergoing primary percutaneous coronary intervention ( PCI ) .